Wang, Y., Mohseni, M., Grauel, A., Diez, J. E., Guan, W., Liang, S., Choi, J. E., Pu, M., Chen, D., Laszewski, T., Schwartz, S., Gu, J., Mansur, L., Burks, T., Brodeur, L., Velazquez, R., Kovats, S., Pant, B., Buruzula, G., Deng, E., Chen, J. T., Sari-Sarraf, F., Dornelas, C., Varadarajan, M., Yu, H., Liu, C., Lim, J., Hao, H., Jiang, X., Malamas, A., LaMarche, M. J., Geyer, F. C., McLaughlin, M., Costa, C., Wagner, J., Ruddy, D., Jayaraman, P., Kirkpatrick, N. D., Zhang, P., Iartchouk, O., Aardalen, K., Cremasco, V., Dranoff, G., Engelman, J. A., Silver, S., Wang, H., Hastings, W. D. and Goldoni, S. SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms. Scientific Reports. 2021; 11(1). doi: 10.1038/s41598-021-80999-x. doi: 10.1038/s41598-021-80999-x